INTU
65
5
DVA
49
2
IVZ
62
-6
ED
36
2
MHK
46
-7
NFLX
37
-3
MDT
60
-3
APD
52
-2
DHI
39
-2
PGR
49
-3
SEE
55
5
AA
72
2
GILD
47
-2
BXP
39
-2
EXPE
83
2
NTAP
67
2
AZO
48
-2
D
37
-6
WHR
53
-8
HPQ
49
-10
INTU
65
5
DVA
49
2
IVZ
62
-6
ED
36
2
MHK
46
-7
NFLX
37
-3
MDT
60
-3
APD
52
-2
DHI
39
-2
PGR
49
-3
SEE
55
5
AA
72
2
GILD
47
-2
BXP
39
-2
EXPE
83
2
NTAP
67
2
AZO
48
-2
D
37
-6
WHR
53
-8
HPQ
49
-10
Financhill
Back

C4 Therapeutics, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
34

CCCC
C4 Therapeutics, Inc.

Last Price:
$2.68
Seasonality Move:
-24.32%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

C4 Therapeutics, Inc. Stock Forecast

  • Is C4 Therapeutics, Inc. Stock Undervalued?
    The current C4 Therapeutics, Inc. [CCCC] share price is $2.67. The Score for CCCC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CCCC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will C4 Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

C4 Therapeutics, Inc. Stock Rating

Data Unavailable

C4 Therapeutics, Inc. Stock Price History

Is CCCC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCCC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
c4therapeutics.com

52-Week Data

52-Week High:
5.10
52-Week Low:
1.09

Prediction Charts

Market Cap:
258.8M
Price in USD:
2.67
Volume:
2M
Beta:
2.96

Technical Analysis

SMA50:
2.41
SMA100:
2.47
SMA200:
2.10
52-Wk Change:
-31.54%

Stock Predictions

  • Is C4 Therapeutics, Inc. stock public?
    Yes, C4 Therapeutics, Inc. is a publicly traded company.
  • What is the C4 Therapeutics, Inc. stock quote today?
    The C4 Therapeutics, Inc. stock price is 2.67 USD today.
  • How to buy C4 Therapeutics, Inc. stock online?
    You can buy C4 Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-17 2.47 2.50 2.55 2.40
Nov-18 2.40 2.48 2.53 2.39
Nov-19 2.48 2.50 2.54 2.44
Nov-20 2.55 2.38 2.63 2.36
Nov-21 2.40 2.44 2.46 2.29
Nov-24 2.40 2.46 2.49 2.40
Nov-25 2.47 2.48 2.50 2.42
Nov-26 2.47 2.68 2.71 2.45
Nov-28 2.72 2.71 2.75 2.61
Dec-1 2.64 2.54 2.65 2.51
Dec-2 2.61 2.43 2.65 2.43
Dec-3 2.45 2.81 2.84 2.41
Dec-4 2.71 2.59 2.75 2.57
Dec-5 2.60 2.67 2.76 2.57

C4 Therapeutics, Inc. Earnings

Data Unavailable

C4 Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.23 per share.

* C4 Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.